$HIPH- PR/News out today is huge! $HIPH #CBD product

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
637
$HIPH- PR/News out today is huge! $HIPH #CBD product LALPINA HYDROGEN CBD now out and will be in MAXIM Superbowl party in Minneapolis. 64million verified outstanding shares. Revenue increase of 1,134% per last PR. $HIPH #Undervalued wont be shocked to see 10 cent in near future.


PLAYA VISTA, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Alfred Culbreth, Founder of American Premium Water Corporation (HIPH) APWC announces that it has created a prototype of its hydrogen-infused CBD water, with plans to release to market during the first half of 2018.

After over a year of development, Alfred Culbreth, Founder and Ryan Fishoff, CEO of APWC, the producer of LALPINA Hydrogen Water and GENTS luxury accessories, are pleased to announce that the company has created a prototype of its hydrogen-infused CBD water and is on track to bring the product to market on schedule in the first half of 2018.

“I am thrilled to announce that after many months of R&D, HIPH has finally been able to produce a beta version of the LALPINA hydrogen-infused CBD water “LALPINA HYDROGEN CBD”. We have perfected the process, and are really excited to bring it to market before the end of the 1st half of 2018.” – Stated Ryan Fishoff, CEO American Premium Water Corporation.

Mr. Culbreth added, “There is no other CBD hydrogen-infused product on the market and we’re happy to be the first to launch, with 100% market share. In many CBD products, upwards of 90% of the CBD nutrients are lost in the digestive process. LALPINA HYDROGEN CBD utilizes hydrogen as a delivery mechanism which allows the CBD nutrients to immediately penetrate into the cells, bypassing into the bloodstream, which yields a greater absorption rate of CBD, creating a more immediate effect.”

Mr. Fishoff continued, “We are currently developing an omni-channel go-to-market strategy that will piggyback on the launch of our LALPINA Hydrogen-infused beverage, which includes digital marketing, direct to consumer, Amazon, and retail distribution. Bringing LALPINA HYDROGEN CBD to market will continue to distinguish LALPINA as the preeminent hydrogen-infused brand. We have also initiated the process of filing intellectual property applications for LALPINA HYDROGEN CBD."

Mr. Fishoff, appointed CEO of HIPH this past September, had outlined his plan to bring the LALPINA HYDROGEN CBD to market as one of the company’s paramount objectives for 2018. Being able to create a working beta version of the drink earlier than expected has HIPH positioned for success in advance of the Company launching LALPNA HYDROGEN at numerous promotional events during Super Bowl week in Minneapolis, Minnesota, the site of Super Bowl LII.

“We are excited about having a large presence during the festivities of Super Bowl week, including the Maxim Super Bowl party. This will be great exposure for our brands and will officially launch LALPINA HYDROGEN. There is no better place to do this than on the world’s biggest stage. Getting our hydrogen drink going will lay the foundation for our CBD infused beverage, which has tremendous potential. The CBD market potential is expected to generate $3 billion in revenue by 2020. Establishing a foothold is key, and the fact that LALPINA is the only product in the category will help us capture a large share of that market right out the gate,” concluded Mr. Fishoff.

CBD, the natural phycannbinoid extracted from cannabis, has many therapeutic benefits, among many other commercial applications. With 700% projected growth over the next few years, APWC is excited to enter this high growth sector, joining other companies such as Pot Network Holding Inc (POTN), Elev8 Brands Inc (VATE), Namaste Technologies (NXTTF), Hemp Americana (HMPQ), and Grow Life Inc (PHOT) who have carved out respective niches in the sector. APWC has made preliminary overtures to a number of companies in the space to explore

Please follow us on our social media outlets listed below:

@americanpremium
@lalpinawater
@GentsCo
#Gentsco
#lalpinahydrogen
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading